Advertisement
Screener

Amgen Inc. (AMGN) Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)

2.3 / 5 stars · 55/120 Roast Me

Amgen Inc. Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)

Amgen Inc. (AMGN) had Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) of $228.00 million as of 2013-03-31, per its 10-Q filed 2013-05-03.

Discontinued › Notes › Investments

us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain · last filed 2013-05-03

  • 2013-03-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $228.00M.
  • 2012-12-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $312.00M.
  • 2012-09-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $344.00M.
  • 2012-06-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $211.00M.
Period endAvailable-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)
2013-03-31$228.00M
10-Q · filed 2013-05-03
2012-12-31$312.00M
10-Q · filed 2013-05-03
2012-09-30$344.00M
10-Q · filed 2012-11-06
2012-06-30$211.00M
10-Q · filed 2012-08-08
2012-03-31$221.00M
10-Q · filed 2012-05-08
2011-12-31$224.00M
10-K · filed 2013-02-27
2011-09-30$227.00M
10-Q · filed 2011-11-04
2011-06-30$209.00M
10-Q · filed 2011-08-08
2010-12-31$256.00M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31